cilobradine and Pituitary-Neoplasms

cilobradine has been researched along with Pituitary-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for cilobradine and Pituitary-Neoplasms

Article	Year
Inhibitory Effective Perturbations of Cilobradine (DK-AH269), A Blocker of HCN Channels, on the Amplitude and Gating of Both Hyperpolarization-Activated Cation and Delayed-Rectifier Potassium Currents. International journal of molecular sciences, 2020, Mar-31, Volume: 21, Issue:7 Cilobradine (CIL, DK-AH269), an inhibitor of hyperpolarization-activated cation current ( Topics: Animals; Benzazepines; Cations; Cell Line, Tumor; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Transport; Ivabradine; Kinetics; Patch-Clamp Techniques; Piperidines; Pituitary Neoplasms; Potassium; Shab Potassium Channels; Sodium	2020

Article

Year

Inhibitory Effective Perturbations of Cilobradine (DK-AH269), A Blocker of HCN Channels, on the Amplitude and Gating of Both Hyperpolarization-Activated Cation and Delayed-Rectifier Potassium Currents.

International journal of molecular sciences, 2020, Mar-31, Volume: 21, Issue:7

Cilobradine (CIL, DK-AH269), an inhibitor of hyperpolarization-activated cation current (

Topics: Animals; Benzazepines; Cations; Cell Line, Tumor; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Transport; Ivabradine; Kinetics; Patch-Clamp Techniques; Piperidines; Pituitary Neoplasms; Potassium; Shab Potassium Channels; Sodium

2020